Sarepta Therapeutics, Inc.
MX ˙ BMV ˙ US8036071004
SecurityMX:SRPT / Sarepta Therapeutics, Inc.
InstitutionBnp Paribas Arbitrage, Sa
Latest Disclosed Ownership699,795 shares
Latest Disclosed Value $ 15,227,539
Bnp Paribas Arbitrage, Sa ownership in SRPT / Sarepta Therapeutics, Inc.

On May 12, 2026 - Bnp Paribas Arbitrage, Sa filed a 13F-HR form disclosing ownership of 699,795 shares of Sarepta Therapeutics, Inc. (MX:SRPT) valued at $15,227,539 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 727,786 shares of Sarepta Therapeutics, Inc.. This represents a change in shares of -3.85% during the quarter.

Bnp Paribas Arbitrage, Sa has a history of taking positions in derivatives of the underlying security (SRPT) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:SRPT / Sarepta Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F Sarepta Therapeutics Equity 803607100 699,795 -27,991 -3.85 15,228 -2.77 0.0008
2026-02-10 2025-12-31 13F Sarepta Therapeutics Equity 803607100 727,786 -1,053,562 -59.14 15,662 -54.38 0.0071
2025-11-13 2025-09-30 13F Sarepta Therapeutics Equity 803607100 1,781,348 547,599 44.38 34,327 62.71 0.0183
2025-08-14 2025-06-30 13F Sarepta Therapeutics Equity 803607100 1,233,749 1,199,741 3,527.82 21,097 872.21 0.0121
2025-05-14 2025-03-31 13F Sarepta Therapeutics Equity 803607100 34,008 6,560 23.90 2,170 -34.97 0.0013
2025-02-14 2024-12-31 13F Sarepta Therapeutics Equity 803607100 27,448 117 0.43 3,337 -2.23 0.0019
2024-11-13 2024-09-30 13F Sarepta Therapeutics Equity 803607100 27,331 -47,495 -63.47 3,413 -71.13 0.0023
2024-08-13 2024-06-30 13F Sarepta Therapeutics Equity 803607100 74,826 -150,556 -66.80 11,823 -59.48 0.0096
2024-05-01 2024-03-31 13F Sarepta Therapeutics Equity 803607100 225,382 76,956 51.85 29,178 103.86 0.0256
2024-02-14 2023-12-31 13F/A-2 Sarepta Therapeutics Equity 803607100 148,426 118,196 390.99 14,313 290.61 0.0162
2024-02-07 2023-12-31 13F/A-1 Sarepta Therapeutics Equity 803607100 148,426 118,196 14,313 0.0020
2024-02-07 2023-12-31 13F Sarepta Therapeutics Equity 803607100 148,426 14,313
2023-11-14 2023-09-30 13F Sarepta Therapeutics Equity 803607100 30,230 9,805 48.00 3,664 56.65 0.0047
2023-08-09 2023-06-30 13F Sarepta Therapeutics Equity 803607100 20,425 -138,576 -87.15 2,339 -89.33 0.0029
2023-05-12 2023-03-31 13F SAREPTA THERAPEUTICS EQUITY 803607100 159,001 121,424 323.13 21,915 350.09 0.0307
2023-02-14 2022-12-31 13F Sarepta Therapeutics Equity 803607100 37,577 37,577 4,869 0.0075
2022-11-15 2022-09-30 13F/A-1 Sarepta Therapeutics Equity 803607100 0 -69,724 -100.00 0 -100.00
2022-11-15 2022-09-30 13F Sarepta Therapeutics Equity 803607100 0 -69,724 0
2022-08-12 2022-06-30 13F Sarepta Therapeutics Equity 803607100 69,724 -61,229 -46.76 5,227 -48.91 0.0082
2022-05-18 2022-03-31 13F/A-1 Sarepta Therapeutics Equity 803607100 130,953 -12,656 -8.81 10,230 -20.89 0.0138
2022-02-09 2021-12-31 13F SAREPTA THERAPEUTICS EQUITY 803607100 143,609 82,625 135.49 12,932 129.31 0.0184
2021-11-16 2021-09-30 13F/A-1 SAREPTA THERAPEUTICS EQUITY 803607100 60,984 24,233 65.94 5,640 97.37 0.0080
2021-11-12 2021-09-30 13F SAREPTA THERAPEUTICS EQUITY 803607100 24,001 -12,750 3,370 0.0000
2021-08-10 2021-06-30 13F SAREPTA THERAPEUTICS EQUITY 803607100 36,751 -6,698 -15.42 2,857 -11.77 0.0038
2021-05-07 2021-03-31 13F SAREPTA THERAPEUTICS EQUITY 803607100 43,449 16,939 63.90 3,238 -28.35 0.0047
2021-02-10 2020-12-31 13F SAREPTA THERAPEUTICS EQUITY 803607100 26,510 2,509 10.45 4,520 34.09 0.0084
2020-10-30 2020-09-30 13F SAREPTA THERAPEUTICS EQUITY 803607100 24,001 -9,354 -28.04 3,370 -36.99 0.0048
2020-08-06 2020-06-30 13F SAREPTA THERAPEUTICS EQUITY 803607100 33,355 -5,320 -13.76 5,348 41.37 0.0094
2020-05-13 2020-03-31 13F SAREPTA THERAPEUTICS EQUITY 803607100 38,675 10,862 39.05 3,783 5.43 0.0078
2020-02-12 2019-12-31 13F SAREPTA THERAPEUTICS EQUITY 803607100 27,813 3,750 15.58 3,589 98.01 0.0065
2019-11-07 2019-09-30 13F SAREPTA THERAPEUTICS EQUITY 803607100 24,063 16,574 221.31 1,812 59.37 0.0032
2019-07-30 2019-06-30 13F SAREPTA THERAPEUTICS EQUITY 803607100 7,489 4,813 179.86 1,138 257.55 0.0023
2019-04-25 2019-03-31 13F SAREPTA THERAPEUTICS EQUITY 803607100 2,676 98 3.80 319 13.17 0.0007
2019-02-12 2018-12-31 13F SAREPTA THERAPEUTICS EQUITY 803607100 2,578 -4,845 -65.27 281 -76.54 0.0007
2018-11-07 2018-09-30 13F SAREPTA THERAPEUTICS EQUITY 803607100 7,423 5,203 234.37 1,199 308.87 0.0018
2018-07-25 2018-06-30 13F SAREPTA THERAPEUTICS EQUITY 803607100 2,220 -15,362 -87.37 293 -77.50 0.0005
2018-05-11 2018-03-31 13F SAREPTA THERAPEUTICS EQUITY 803607100 17,582 1,907 12.17 1,303 49.31 0.0024
2018-03-05 2017-12-31 13F/A-1 SAREPTA THERAPEUTICS EQUITY 803607100 15,675 8,883 130.79 872 183.12 0.0015
2018-02-01 2017-12-31 13F SAREPTA THERAPEUTICS EQUITY 803607100 15,675 8,883 872
2017-11-03 2017-09-30 13F SAREPTA THERAPEUTICS STOCK 803607100 6,792 303 4.67 308 41.28 0.0008
2017-08-03 2017-06-30 13F SAREPTA THERAPEUTICS STOCK 803607100 6,489 5,306 448.52 219 522.86 0.0007
2017-05-03 2017-03-31 13F SAREPTA THERAPEUTICS STOCK 803607100 1,183 -721 -37.87 35 -32.69 0.0001
2017-02-14 2016-12-31 13F SAREPTA THERAPEUTICS STOCK 803607100 1,904 -1,637 -46.23 52 -76.04 0.0002
2016-10-05 2016-09-30 13F * SAREPTA THERAPEUTICS INC COM STOCK 803607100 3,541 1,886 113.96 217 600.00 0.0009
2016-07-06 2016-06-30 13F * SAREPTA THERAPEUTICS INC COM STOCK 803607100 1,655 1,655 0.00 32 0.0001
2016-04-22 2016-03-31 13F * SAREPTA THERAPEUTICS INC COM STOCK 803607100 0 -4,780 -100.00 0 -100.00
2016-04-19 2015-12-31 13F/A-1 * SAREPTA THERAPEUTICS INC COM STOCK 803607100 4,780 -3,838 -44.53 184 -33.33 0.0009
2016-02-10 2015-12-31 13F * SAREPTA THERAPEUTICS INC COM STOCK 803607100 4,780 184
2015-11-13 2015-09-30 13F * SAREPTA THERAPEUTICS INC COM STOCK 803607100 8,618 5,169 149.87 277 165.38 0.0007
2015-08-14 2015-06-30 13F SAREPTA THERAPEUTICS INC COM STOCK 803607100 3,449 2,475 254.11 105 766.67 0.0003
2015-05-15 2015-03-31 13F * SAREPTA THERAPEUTICS INC COM STOCK 803607100 974 974 0.00 13 0.0000
2015-02-11 2014-12-31 13F * SAREPTA THERAPEUTICS INC COM STOCK 803607100 0 -2,345 -100.00 0 -100.00
2014-11-12 2014-09-30 13F * SAREPTA THERAPEUTICS INC COM STOCK 803607100 2,345 1,910 439.08 49 512.50 0.0000
2014-04-02 2013-12-31 13F/A-1 SAREPTA THERAPEUTICS STOCK 803607100 435 -8,571 -95.17 9 -98.12 0.0000
2013-11-13 2013-09-30 13F SAREPTA THERAPEUTICS STOCK 803607100 9,006 -3,756 -29.43 425 -12.37 0.0003
2013-08-13 2013-06-30 13F SAREPTA THERAPEUTICS STOCK 803607100 12,762 12,762 485 0.0003
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-13 2025-09-30 13F Sarepta Therapeutics Option Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-14 2025-06-30 13F Sarepta Therapeutics Option Put 400 684 n/a n/a n/a
2025-05-14 2025-03-31 13F Sarepta Therapeutics Option Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F Sarepta Therapeutics Option Put 10 122 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.